Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1958 1
1959 3
1960 1
1961 3
1962 2
1963 6
1964 2
1965 3
1966 8
1967 2
1968 2
1970 1
1971 2
1974 2
1976 1
1980 4
1981 1
1982 4
1983 2
1984 2
1985 4
1986 8
1987 8
1988 7
1989 6
1990 12
1991 7
1992 4
1993 8
1994 5
1995 4
1996 10
1997 9
1998 10
1999 7
2000 6
2001 7
2002 9
2003 13
2004 10
2005 15
2006 16
2007 18
2008 19
2009 17
2010 16
2011 21
2012 18
2013 29
2014 24
2015 24
2016 20
2017 22
2018 11
2019 12
2020 21
2021 20
Text availability
Article attribute
Article type
Publication date

Search Results

475 results
Results by year
Filters applied: . Clear all
Page 1
Lenalidomide for the treatment of mantle cell lymphoma.
Morabito F, Skafi M, Recchia AG, Kashkeesh A, Hindiyeh M, Sabatleen A, Morabito L, Alijanazreh H, Hamamreh Y, Gentile M. Morabito F, et al. Expert Opin Pharmacother. 2019 Apr;20(5):487-494. doi: 10.1080/14656566.2018.1561865. Epub 2019 Jan 4. Expert Opin Pharmacother. 2019. PMID: 30608891 Review.
Venetoclax for the treatment of chronic lymphocytic leukemia.
Gentile M, Petrungaro A, Uccello G, Vigna E, Recchia AG, Caruso N, Bossio S, De Stefano L, Palummo A, Storino F, Martino M, Morabito F. Gentile M, et al. Among authors: morabito f. Expert Opin Investig Drugs. 2017 Nov;26(11):1307-1316. doi: 10.1080/13543784.2017.1386173. Epub 2017 Oct 9. Expert Opin Investig Drugs. 2017. PMID: 28972395 Review.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Condoluci A, Terzi di Bergamo L, Langerbeins P, Hoechstetter MA, Herling CD, De Paoli L, Delgado J, Rabe KG, Gentile M, Doubek M, Mauro FR, Chiodin G, Mattsson M, Bahlo J, Cutrona G, Kotaskova J, Deambrogi C, Smedby KE, Spina V, Bruscaggin A, Wu W, Moia R, Bianchi E, Gerber B, Zucca E, Gillessen S, Ghielmini M, Cavalli F, Stussi G, Hess MA, Baumann TS, Neri A, Ferrarini M, Rosenquist R, Forconi F, Foà R, Pospisilova S, Morabito F, Stilgenbauer S, Döhner H, Parikh SA, Wierda WG, Montserrat E, Gaidano G, Hallek M, Rossi D. Condoluci A, et al. Among authors: morabito f. Blood. 2020 May 21;135(21):1859-1869. doi: 10.1182/blood.2019003453. Blood. 2020. PMID: 32267500 Free article.
European Myeloma Network guidelines for the management of multiple myeloma-related complications.
Terpos E, Kleber M, Engelhardt M, Zweegman S, Gay F, Kastritis E, van de Donk NW, Bruno B, Sezer O, Broijl A, Bringhen S, Beksac M, Larocca A, Hajek R, Musto P, Johnsen HE, Morabito F, Ludwig H, Cavo M, Einsele H, Sonneveld P, Dimopoulos MA, Palumbo A; European Myeloma Network. Terpos E, et al. Among authors: morabito f. Haematologica. 2015 Oct;100(10):1254-66. doi: 10.3324/haematol.2014.117176. Haematologica. 2015. PMID: 26432383 Free PMC article.
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma.
Morabito F, Recchia AG, Vigna E, Botta C, Skafi M, Abu-Rayyan M, Atrash M, Galimberti S, Morabito L, Al-Janazreh H, Martino M, Cutrona G, Gentile M. Morabito F, et al. Expert Opin Pharmacother. 2020 Jan;21(1):29-38. doi: 10.1080/14656566.2019.1689959. Epub 2019 Nov 18. Expert Opin Pharmacother. 2020. PMID: 31738609 Review.
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
Oliva EN, Alati C, Santini V, Poloni A, Molteni A, Niscola P, Salvi F, Sanpaolo G, Balleari E, Germing U, Fenaux P, Stamatoullas A, Palumbo GA, Salutari P, Impera S, Avanzini P, Cortelezzi A, Liberati AM, Carluccio P, Buccisano F, Voso MT, Mancini S, Kulasekararaj A, Morabito F, Bocchia M, Cufari P, Spiriti MA, Santacaterina I, D'Errigo MG, Bova I, Zini G, Latagliata R. Oliva EN, et al. Among authors: morabito f. Lancet Haematol. 2017 Mar;4(3):e127-e136. doi: 10.1016/S2352-3026(17)30012-1. Epub 2017 Feb 3. Lancet Haematol. 2017. PMID: 28162984 Clinical Trial.
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study.
Gentile M, Morabito F, Del Poeta G, Mauro FR, Reda G, Sportoletti P, Laurenti L, Coscia M, Herishanu Y, Recchia AG, Varettoni M, Murru R, Chiarenza A, Condoluci A, Moia R, Pietrasanta D, Loseto G, Consoli U, Scortechini I, Rossi FM, Zucchetto A, Fraticelli V, Vigna E, Botta C, Tripepi G, Arrigo G, Rago A, Angeletti I, Biagi A, Del Giudice I, Bomben R, Rigolin GM, Rossi D, Di Raimondo F, Gaidano G, Polliack A, Cuneo A, Foà R, Gattei V. Gentile M, et al. Among authors: morabito f. Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14. Leukemia. 2021. PMID: 32286543 No abstract available.
475 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page